Colon Cancer Screening Recommendations

1. Initiation of Screening in Average‑Risk Adults

Begin routine colorectal cancer screening at age 50 with colonoscopy every 10 years or annual fecal immunochemical testing (FIT); this recommendation is strong and based on high‑quality evidence from randomized trials demonstrating mortality reduction. [1][2]
Consider initiating screening at age 45 when resources allow and patients express concern, but this carries a qualified/weak recommendation because it relies on epidemiologic modeling rather than direct outcome data. 1

Start screening at age 40 or 10 years before the youngest affected first‑degree relative’s diagnosis (whichever occurs first) when there is one first‑degree relative with colorectal cancer or advanced adenoma diagnosed before age 60, or two first‑degree relatives diagnosed at any age; this is a strong recommendation. [2][3]
In this high‑risk group, perform colonoscopy every 5 years (instead of the 10‑year interval for average risk). 2
If the affected first‑degree relative was diagnosed at age 60 or older, the screening interval reverts to the average‑risk schedule (colonoscopy every 10 years or annual FIT). 2

Consider initiating screening at age 45 because of higher colorectal cancer incidence in this population; the evidence quality is limited, resulting in a weak recommendation. [2][3]

Colonoscopy every 10 years is the gold‑standard test, allowing simultaneous detection and removal of polyps; strong recommendation with high‑quality evidence. [1][2]
Annual FIT is an equally endorsed first‑tier option, especially suitable for organized population‑based programs; strong recommendation with high‑quality evidence. [1][2]

CT colonography every 5 years is an acceptable alternative, though it involves radiation exposure; moderate recommendation. [1][2]
Multitarget stool DNA (FIT‑DNA) testing every 3 years is reasonable for patients refusing colonoscopy and FIT; moderate recommendation. [1][2]
Flexible sigmoidoscopy every 5–10 years examines only the distal colon and may miss proximal lesions; moderate recommendation. [1][2]

Cease routine screening at age 75 if the patient is up‑to‑date with prior negative tests, particularly after a recent high‑quality colonoscopy; strong recommendation. 1
Stop screening at any age when life expectancy is estimated to be less than 10 years, regardless of prior screening history; strong recommendation. 1
For ages 76–85, offer screening only to individuals who have never been screened previously after evaluating overall health, comorbidities, and ability to tolerate treatment if cancer were detected; moderate recommendation. 1
Do not offer routine screening to those already up‑to‑date with prior negative tests in the 76–85 age range; moderate recommendation. 1
Discontinue all screening at age 86 and older because harms outweigh benefits; strong recommendation. 1

Positive results from any non‑colonoscopy test must be followed promptly by diagnostic colonoscopy; strong recommendation. 1
Do not assume all family‑history scenarios confer the same risk; documentation of relatives’ cancer status and exact age at diagnosis is essential to determine screening intensity. 2
Patients with inflammatory bowel disease or hereditary cancer syndromes (e.g., Lynch syndrome, familial adenomatous polyposis) require dedicated surveillance protocols and should not be managed with general population screening recommendations. [2][4]

Begin screening at age 45 with either colonoscopy every 10 years or annual fecal immunochemical test (FIT), and continue through age 75. This is a qualified recommendation because outcome data for ages 45‑49 are limited. 5, 6, 7
Screening from ages 50‑75 is a strong (Grade A) recommendation supported by high‑quality evidence from the U.S. Preventive Services Task Force. 5, 7
Colonoscopy every 10 years is a first‑tier modality that allows simultaneous detection and removal of polyps. 5, 7
Annual FIT is an equally ranked first‑tier option and is often preferred in organized population‑based programs. 5
CT colonography every 5 years is an accepted second‑tier screening test. 5, 7
Multitarget stool DNA testing (FIT‑DNA) every 3 years is a second‑tier option for average‑risk adults. 5, 6
Flexible sigmoidoscopy every 5‑10 years can be used as a second‑tier screening strategy. 5, 6, 7
Discontinue routine screening at age 75 if the patient is up‑to‑date with prior negative tests (e.g., a recent colonoscopy). 6, 7
For ages 76‑85, screening decisions should be individualized based on life expectancy, overall health status, and prior screening history. 6, 7
Do not screen individuals older than 85 years, as harms outweigh potential benefits. 6

One first‑degree relative with colorectal cancer (CRC) diagnosed < 60 years: start colonoscopy at age 40 or 10 years before the relative’s diagnosis age (whichever is earlier) and repeat every 5 years. 5, 7
One first‑degree relative with CRC diagnosed ≥ 60 years: begin screening at age 40 using average‑risk options (colonoscopy every 10 years or annual FIT). 5, 7
First‑degree relative with advanced adenoma diagnosed < 60 years: follow the same protocol as for CRC diagnosed < 60 years (colonoscopy at age 40 or 10 years before diagnosis, repeat every 5 years). 5, 7
Second‑ or third‑degree relatives with CRC: initiate colonoscopy at age 45 and repeat every 10 years. 5, 7
Verification of the exact age at diagnosis of affected relatives is essential because the 60‑year cutoff determines whether 5‑year or 10‑year colonoscopy intervals are recommended. 5, 7